Rebus Holdings, Inc. (RBSH)

Market Cap	32.00 -99.0%
Revenue (ttm)	n/a
Net Income	570.00K -86.4%
EPS	0.02 +246.2%
Shares Out	32.13M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	134
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0001
Beta	-37.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Rebus Holdings

Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RBSH

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 1, 2026

Data Sources Report a data error